Albertsons Companies, Inc. (NYSE:ACI) reported Tuesday fourth-quarter fiscal 2025 results for the period ended Feb. 28, 2026, with adjusted earnings per share of 48 cents, beating the 43 cents analyst estimate.
The company’s shares traded lower following the release.
Revenue came in at $20.25 billion, missing analyst expectations of $20.47 billion.
The company posted a net loss of $480.8 million, or 94 cents per share, versus net income of $171.8 million, or 29 cents per share, in the prior year period.
Results for the quarter include a $773.8 million charge tied to the Opioid Settlement Framework recorded in the fourth quarter of fiscal 2025.
Sales increased from $18.8 billion a year earlier, including approximately $1.4 billion from an extra week in the quarter.
Identical sales rose 0.7%, driven primarily by pharmacy, which faced pricing headwinds tied to the Inflation Reduction Act and industry mix shifts. Digital sales increased 16%, and loyalty membership grew 12% to 51.2 million.
Profit Impacted by Opioid Charge, Margins Under Pressure
Adjusted net income was $251.7 million, or 48 cents per share, up from …